410 related articles for article (PubMed ID: 19822741)
1. Glycans on influenza hemagglutinin affect receptor binding and immune response.
Wang CC; Chen JR; Tseng YC; Hsu CH; Hung YF; Chen SW; Chen CM; Khoo KH; Cheng TJ; Cheng YS; Jan JT; Wu CY; Ma C; Wong CH
Proc Natl Acad Sci U S A; 2009 Oct; 106(43):18137-42. PubMed ID: 19822741
[TBL] [Abstract][Full Text] [Related]
2. Unmasking Stem-Specific Neutralizing Epitopes by Abolishing N-Linked Glycosylation Sites of Influenza Virus Hemagglutinin Proteins for Vaccine Design.
Liu WC; Jan JT; Huang YJ; Chen TH; Wu SC
J Virol; 2016 Oct; 90(19):8496-508. PubMed ID: 27440889
[TBL] [Abstract][Full Text] [Related]
3. Influenza Virus Hemagglutinins H2, H5, H6, and H11 Are Not Targets of Pulmonary Surfactant Protein D:
Parsons LM; An Y; Qi L; White MR; van der Woude R; Hartshorn KL; Taubenberger JK; de Vries RP; Cipollo JF
J Virol; 2020 Feb; 94(5):. PubMed ID: 31826991
[TBL] [Abstract][Full Text] [Related]
4. Broadly neutralizing DNA vaccine with specific mutation alters the antigenicity and sugar-binding activities of influenza hemagglutinin.
Chen MW; Liao HY; Huang Y; Jan JT; Huang CC; Ren CT; Wu CY; Cheng TJ; Ho DD; Wong CH
Proc Natl Acad Sci U S A; 2011 Mar; 108(9):3510-5. PubMed ID: 21321237
[TBL] [Abstract][Full Text] [Related]
5. Addition of N-glycosylation sites on the globular head of the H5 hemagglutinin induces the escape of highly pathogenic avian influenza A H5N1 viruses from vaccine-induced immunity.
Hervé PL; Lorin V; Jouvion G; Da Costa B; Escriou N
Virology; 2015 Dec; 486():134-45. PubMed ID: 26433051
[TBL] [Abstract][Full Text] [Related]
6. Immunization by avian H5 influenza hemagglutinin mutants with altered receptor binding specificity.
Yang ZY; Wei CJ; Kong WP; Wu L; Xu L; Smith DF; Nabel GJ
Science; 2007 Aug; 317(5839):825-8. PubMed ID: 17690300
[TBL] [Abstract][Full Text] [Related]
7. Structural characterization of the hemagglutinin receptor specificity from the 2009 H1N1 influenza pandemic.
Xu R; McBride R; Nycholat CM; Paulson JC; Wilson IA
J Virol; 2012 Jan; 86(2):982-90. PubMed ID: 22072785
[TBL] [Abstract][Full Text] [Related]
8. Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus.
Stevens J; Blixt O; Tumpey TM; Taubenberger JK; Paulson JC; Wilson IA
Science; 2006 Apr; 312(5772):404-10. PubMed ID: 16543414
[TBL] [Abstract][Full Text] [Related]
9. Hemagglutinin amino acids related to receptor specificity could affect the protection efficacy of H5N1 and H7N9 avian influenza virus vaccines in mice.
Xu L; Bao L; Lau SY; Wu WL; Yuan J; Gu S; Li F; Lv Q; Xu Y; Pushko P; Chen H; Qin C
Vaccine; 2016 May; 34(23):2627-33. PubMed ID: 27083426
[TBL] [Abstract][Full Text] [Related]
10. Influenza Virus Hemagglutinin Glycoproteins with Different N-Glycan Patterns Activate Dendritic Cells In Vitro.
Liu WC; Lin YL; Spearman M; Cheng PY; Butler M; Wu SC
J Virol; 2016 Jul; 90(13):6085-6096. PubMed ID: 27099319
[TBL] [Abstract][Full Text] [Related]
11. Enhanced Human-Type Receptor Binding by Ferret-Transmissible H5N1 with a K193T Mutation.
Peng W; Bouwman KM; McBride R; Grant OC; Woods RJ; Verheije MH; Paulson JC; de Vries RP
J Virol; 2018 May; 92(10):. PubMed ID: 29491160
[TBL] [Abstract][Full Text] [Related]
12. Egg-based influenza split virus vaccine with monoglycosylation induces cross-strain protection against influenza virus infections.
Tseng YC; Wu CY; Liu ML; Chen TH; Chiang WL; Yu YH; Jan JT; Lin KI; Wong CH; Ma C
Proc Natl Acad Sci U S A; 2019 Mar; 116(10):4200-4205. PubMed ID: 30782805
[TBL] [Abstract][Full Text] [Related]
13. A Replication-Defective Influenza Virus Harboring H5 and H7 Hemagglutinins Provides Protection against H5N1 and H7N9 Infection in Mice.
Tian X; Landreth S; Lu Y; Pandey K; Zhou Y
J Virol; 2021 Jan; 95(3):. PubMed ID: 33177192
[TBL] [Abstract][Full Text] [Related]
14. Glycan microarray technologies: tools to survey host specificity of influenza viruses.
Stevens J; Blixt O; Paulson JC; Wilson IA
Nat Rev Microbiol; 2006 Nov; 4(11):857-64. PubMed ID: 17013397
[TBL] [Abstract][Full Text] [Related]
15. Computationally Optimized Broadly Reactive Hemagglutinin Elicits Hemagglutination Inhibition Antibodies against a Panel of H3N2 Influenza Virus Cocirculating Variants.
Wong TM; Allen JD; Bebin-Blackwell AG; Carter DM; Alefantis T; DiNapoli J; Kleanthous H; Ross TM
J Virol; 2017 Dec; 91(24):. PubMed ID: 28978710
[TBL] [Abstract][Full Text] [Related]
16. Cross-neutralization of 1918 and 2009 influenza viruses: role of glycans in viral evolution and vaccine design.
Wei CJ; Boyington JC; Dai K; Houser KV; Pearce MB; Kong WP; Yang ZY; Tumpey TM; Nabel GJ
Sci Transl Med; 2010 Mar; 2(24):24ra21. PubMed ID: 20375007
[TBL] [Abstract][Full Text] [Related]
17. Glycosylation of the Hemagglutinin Protein of H5N1 Influenza Virus Increases Its Virulence in Mice by Exacerbating the Host Immune Response.
Zhao D; Liang L; Wang S; Nakao T; Li Y; Liu L; Guan Y; Fukuyama S; Bu Z; Kawaoka Y; Chen H
J Virol; 2017 Apr; 91(7):. PubMed ID: 28100622
[TBL] [Abstract][Full Text] [Related]
18. Potential Role of Nonneutralizing IgA Antibodies in Cross-Protective Immunity against Influenza A Viruses of Multiple Hemagglutinin Subtypes.
Okuya K; Yoshida R; Manzoor R; Saito S; Suzuki T; Sasaki M; Saito T; Kida Y; Mori-Kajihara A; Kondoh T; Sato M; Kajihara M; Miyamoto H; Ichii O; Higashi H; Takada A
J Virol; 2020 Jun; 94(12):. PubMed ID: 32269119
[TBL] [Abstract][Full Text] [Related]
19. Influenza virus-like particle can accommodate multiple subtypes of hemagglutinin and protect from multiple influenza types and subtypes.
Pushko P; Pearce MB; Ahmad A; Tretyakova I; Smith G; Belser JA; Tumpey TM
Vaccine; 2011 Aug; 29(35):5911-8. PubMed ID: 21723354
[TBL] [Abstract][Full Text] [Related]
20. Free energy simulations reveal a double mutant avian H5N1 virus hemagglutinin with altered receptor binding specificity.
Das P; Li J; Royyuru AK; Zhou R
J Comput Chem; 2009 Aug; 30(11):1654-63. PubMed ID: 19399777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
